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Tinea Incognito in Korea and Its Risk Factors: Nine-Year 
Multicenter Survey 
Tinea incognito (TI) is a dermatophytic infection which has lost its typical clinical 
appearance because of improper use of steroids or calcineurin inhibitors. The 
incidence of TI is increasing nowadays. We conducted retrospective review on 283 
patients with TI from 25 dermatology training hospitals in Korea from 2002–2010 
to investigate the demographical, clinical, and mycological characteristics of TI, 
and to determine the associated risk factors. More than half (59.3%) patients were 
previously treated by non-dermatologists or self-treated. The mean duration of TI 
was 15.0 ± 25.3 months. The most common clinical manifestations were eczema-
like lesion, psoriasis-like, and lupus erythematosus-like lesion. The trunk and face 
were frequently involved, and 91 patients (32.2%) also had coexisting fungal 
infections. Among 67 isolated strains, Trichophyton rubrum was the most 
frequently detected (73.1%). This is the largest study of TI reported to date and the 
first investigational report concerning TI in Korea. We suggest that doctors should 
consider TI when a patient has intractable eczema-like lesions accompanied by 
tinea pedis/unguium. Furthermore, there should be a policy change, which would 
make over-the-counter high-potency topical steroids less accessible in some 
countries, including Korea. 
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INTRODUCTION
Tinea incognito (TI) is the term given to a dermatophyte infec-
tion, which has been modified in appearance by improper use 
of steroids or calcineurin inhibitors (1, 2). Since it was first de-
scribed by Ive and Marks in 1968 (3), a few case reports and a 
number of review articles have been published on TI in English 
journals (1, 2, 4-6). Though typical dermatophytic infection on 
most skin surfaces except scalp, volar areas and nails usually 
present as annular lesions with erythematous scaly border and 
central clearing. Therefore, dermatophytic infection may be 
confused with other skin disorders such as granuloma annu-
lare, discoid lupus erythematosus, pityriasis rosea, erythema 
annulare centrifugum, erythema migrans, or other dermato-
logical lesions (7). Most textbooks or review articles state that 
mycological confirmation with laboratory testing before the 
start of antifungal therapy is recommended because the clinical 
diagnosis of fungal presence could be inaccurate (8). However, 
this is not easy to do in practice because of time pressure, inad-
equate access to equipment, lack of experience, low reproduc-
ibility, and so on (8, 9). Misdiagnosed dermatophytic disorders 
could be treated improperly with steroids. As some high-poten-
cy topical steroids are easily accessible as over-the-counter 
(OTC) products and non-dermatologists can also prescribe 
topical steroids freely without any fungal examination, the inci-
dence of TI seems to be gradually increasing in Korea (10). 
However, there has been no published large-scale study on TI 
in Korea, as yet. For this reason, we investigated the demo-
graphics and past medical histories of TI patients, and clinical 
and mycological characteristics of TI in Korea. 
MATERIALS AND METHODS
Patients 
In the period from 2002 to 2010, cases of TI were collected ret-
rospectively from dermatologic departments of 25 general hos-
pitals in Korea, which had a dermatology training program. We 
defined 4 criteria for diagnosis of TI: 1) loss of typical clinical 
appearance of tinea (Fig. 1A); 2) previous history of corticoste-
roid (topical or systemic) or calcineurin inhibitor application to 
present lesions; 3) positive for at least 1 mycological evaluation 
(KOH examination, mycologic culture, or skin biopsy with D-
PAS stain); and 4) improvement after antifungal treatment. To 
be enrolled in this study, all patients had to satisfy all the 4 diag-
nostic criteria listed above. Only the cases confined to dorsum 
of hands and feet were included to avoid confusion with tinea 
pedis and tinea manus.
Ethics statement
The study protocol was approved by Institutional Review Boards 
or Ethics Committees of Pusan National University Hospital and 
informed consent was obtained. 
Fig. 1. Various features of tinea incognito (A-G). Vitiligo-like (A; pre-treatment, B; after 4 weeks of application of topical pimecrolimus, C; 6 weeks after topical antifungal treat-
ment), contact dermatitis-like (D), nonspecific eczema-like (E), seborrheic dermatitis-like (F), and lupus erythematosus-like (G) lesions. 
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Demographics, past histories, and clinical characteristics 
Clinical data including charts and clinical photos from 25 hos-
pitals were systematically and retrospectively reviewed. Demo-
graphic information included age, gender, coexisting diseases, 
and other dermatologic diseases. Past medical histories includ-
ed the duration of TI, how the patients obtained the topical ste-
roid or calcineurin inhibitor, and treatment modality. After divid-
ing the patients into 3 groups (dermatologist-treated, non-der-
matologist-treated, and self-treated TI groups), the duration of 
TI and treatment modality were compared among the 3 groups. 
Regarding the clinical characteristics of TI, the distribution, the 
most likely clinical feature, and coexisting fungal infections were 
investigated. 
Mycological data
The KOH examination (20% potassium hydroxide) was per-
formed to check for the presence of fungi. Mycological culture 
was performed on Sabouraud dextrose agar with chloramphe- 
nicol and cycloheximide. After incubation at 25°C for at least 
3 weeks, dermatophytes were identified by means of gross mor-
phology, light microscopy, and/or biopsy with PAS stain (11). 
Statistical analysis 
Pearson’s chi-square test was used to compare the frequency of 
treatment modalities and one-way ANOVA was used to com-
pare the duration of TI among dermatologist-treated, non-der-
matologist-treated, and self-treated TI patients group. A P  value 
of less than 0.05 was considered statistically significant. 
RESULTS
Demographics 
After thorough review, 283 patients fulfilled the diagnostic cri-
teria of TI in this study. The mean age was 44.0 ± 22.5 yr (range 
3-94) and 125 patients (44.3%) were female. Table 1 shows the 
age distribution of TI patients with a slightly lower frequency of 
patients with TI under 10 and over 80 yr old. Sixty-five patients 
(23.0%) had coexisting diseases at first clinic visit such as hyper-
tension in 37 (13.1%), diabetes in 23 (8.1%), and hepatitis in 7 
(2.5%). Five patients had underlying malignancy (1.8%), 2 patients 
suffered from angina, and 2 patients had asthma. In addition, 
1 patient had adrenal insufficiency, 1 patient had myasthenia 
gravis, 1 had depression, and 1 had epilepsy. Sixteen patients 
(5.7%) had coexisting dermatologic diseases including 5 pa-
tients with atopic dermatitis (1.8%), 4 patients with psoriasis 
(1.4%), 3 with systemic lupus erythematosus (1.1%), and 2 with 
Table 1. Demographics and past histories of 283 cases of tinea incognito in Korea 
during 2002-2010 
Parameters No. (%)
No. of patients   283 (100.0)
Male: Female, No. (%)  158:125 (55.7:44.3)
Mean age (yr)       44.6 ± 22.3 (range 3-94)
Age distribution, No. (%)
   0-10 
   11-20 
   21-30 
   31-40 
   41-50 
   51-60 
   61-70 
   71-80 
   81-90 
  > 90 
 
24 (8.5)
25 (8.8)
  31 (11.0)
  38 (13.4)
  40 (14.1)
  41 (14.5)
  44 (15.5)
  33 (11.7)
  6 (2.1)
  1 (0.4)
Coexisting disease, No. (%)
   Hypertension
   Diabetes
   Hepatitis
   Malignancy
   Angina
   Asthma
   Others 
  65 (23.0)
  37 (13.1)
23 (8.1)
  7 (2.5)
  5 (1.8)
  2 (0.7)
  2 (0.7)
  4 (1.4)
Coexisting dermatologic diseases, No. (%)
   Atopic dermatitis
   Psoriasis 
   Systemic lupus erythematosus
   Seborrheic dermatitis
   Others (rosacea, bullous pemphigoid)
16 (5.7)
  5 (1.8)
  4 (1.4)
  3 (1.1)
  2 (0.7)
  2 (0.7)
Table 2. Mean duration of the disease and previous treatment modalities according to past physician’s specialty 
Disease status Dermatologists Non-dermatologists Self-treatment † Total P  value*
Mean duration of the disease (mo± SD) 16.4 ± 25.8 15.7 ± 28.1 9.0 ± 11.1 15.0 ± 25.3 0.234
Treatment modalities, No. (%)
   Topical steroid only
   Systemic steroid only
   Topical and systemic steroid
   Topical steroid and topical calcineurin inhibitor 
   Topical steroid and systemic antibiotics
   Steroid intralesional injection
   Topical steroid and steroid intralesional injection
   Systemic steroid and topical calcineurin inhibitor
   Systemic steroid and topical antibiotics
   Topical calcineurin inhibitor only
 
  90 (31.8)
-
  9 (3.2)
  8 (2.8)
  2 (0.7)
  1 (0.4)
  1 (0.4)
  1 (0.4)
  1 (0.4)
  2 (0.7)
 
112 (39.6)
-
  9 (3.2)
  1 (0.4)
  2 (0.7)
-
-
-
-
-
 
44 (15.5)
-
-
-
-
-
-
-
-
-
 
246 (86.9)
-
18 (6.4)
  9 (3.2)
  4 (1.4)
  1 (0.4)
  1 (0.4)
  1 (0.4)
  1 (0.4)
  2 (0.7)
 
< 0.001
-
0.175
0.010
0.692
0.224
0.474
0.474
0.474
0.224
Total, N (%) 115 (40.6) 124 (43.8) 44 (15.5)   283 (100.0)
*P value < 0.05 considered statistically significant; using one-way ANOVA test in mean duration and Pearson’s chi-square test in treatment modalities; †For children younger 
than 12, self-treatment group also include treatment by parents or others. 
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seborrheic dermatitis (0.7%). There was 1 patient with rosacea, 
and 1 patient with bullous pemphigoid. 
Past medical histories
The mean duration of TI in the study patients was 15.0 ± 25.3 
months. While mean duration of self-treated TI patients was 
9.0 ± 11.1 months, that of TI patients treated by dermatologists 
and non-dermatologists was 16.4 ± 25.8 and 15.7 ± 28.1 months, 
respectively. There was no statistical significance among the 3 
groups (P = 0.234) (Table 2). 
 Before coming to the teaching hospital, 40.6% of TI patients 
received treatment from a dermatologist, 43.8% from non-der-
matologists, and another 15.5% were self-treated. While all of 
self-treated patients used topical steroids only, people treated 
by dermatologists or non-dermatologists used various treatment 
modalities such as topical/systemic steroids, topical/systemic 
antibiotics, topical calcineurin inhibitor, steroid intralesional 
injection, or a combination of aforementioned agents. Overall, 
most of TI patients were treated with topical steroids only (86.9%), 
and other treatment modalities included topical and systemic 
steroids (6.4%), topical steroid and topical calcineurin inhibitor 
(1.4%), and topical calcineurin inhibitor (0.7%), etc. There were 
no significant differences in treatment modalities according to 
past physician’s specialty (P > 0.05). 
Clinical characteristics  
Overall, the trunk (30.4%) is the most commonly affected area 
of TI followed by the face (24.4%), foot (13.8%), multiple involve-
ments (13.8%), the groin (9.9%), and hand (7.8%) (Table 3). The 
clinical features were variable, but regardless of distribution, 
over more than three-quarters of all study patients showed ec-
zema-like (82.0%) lesions which included nonspecific eczema, 
contact dermatitis, seborrheic dermatitis, and atopic dermatitis. 
Less often, TI mimicked psoriasis (6.0%), lupus erythematosus 
Table 3. Clinical and mycological characteristics of 283 cases of tinea incognito in Korea during 2002-2010 
TI distribution Face Trunk Groin Hand* Foot* Multiple Total
Clinical manifestation, No. (%)
   Eczema-like
      Nonspecific eczema
      Contact dermatitis
      Atopic dermatitis
      Seborrheic dermatitis
      Diaper dermatitis
      Intertrigo
      Nummular dermatitis
      Stasis dermatitis
   Psoriasis-like
   Lupus erythematosus-like
   Impetigo-like
   Urticaria-like
   Folliculitis-like
   Lichen simplex chronicus-like
   Vitiligo-like
   Xerosis-like
   Others
69 (24.4)
53 (76.8)
30 (43.5)
16 (23.2)
3 (4.3)
3 (4.3)
-
-
1 (1.4)
-
1 (1.4)
6 (8.7)
2 (2.9)
1 (1.4)
1 (1.4)
-
2 (2.9)
-
3 (4.3)
86 (30.4)
68 (79.1)
54 (62.8)
8 (9.3)
1 (1.2)
1 (1.2)
2 (2.3)
1 (1.2)
-
1 (1.2)
9 (10.5)
-
2 (2.3)
1 (1.2)
-
1 (1.2)
-
-
5 (5.8)
28 (9.9)
25 (89.3)
25 (89.3)
-
-
-
-
-
-
-
1 (3.6)
-
-
1 (3.6)
-
-
-
-
1 (3.6)
22 (7.8)
22 (100.0)
19 (86.4)
3 (13.6)
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
39 (13.8)
37 (94.9)
35 (89.7)
1 (2.6)
1 (2.6)
-
-
-
-
-
-
-
-
-
-
-
-
2 (5.1)
-
39 (13.8)
27 (69.2)
23 (59.0)
4 (10.3)
-
-
-
-
-
-
6 (15.4)
1 (2.6)
-
-
1 (2.6)
1 (2.6)
-
-
3 (7.7)
283 (100.0)
232 (82.0)
186 (65.7)
32 (11.3)
5 (1.8)
4 (1.4)
2 (0.7)
1 (0.4)
1 (0.4)
1 (0.4)
17 (6.0)
7 (2.5)
4 (1.4)
3 (1.1)
2 (0.7)
2 (0.7)
2 (0.7)
2 (0.7)
12 (4.2)
The percentage of children 
   (age < 12, N = 28)
8 (28.6) 10 (35.7) 1 (3.6) 2 (7.1) 4 (14.3) 3 (10.7) 28 (100.0)
Combined fungal disease‡
   T. pedis
   T. unguium
   T. pedis et unguium 
12 (4.2)
4 (33.3)
1 (8.3)
7 (58.3)
24 (8.5)
16 (66.7)
5 (20.8)
3 (12.5)
11 (3.9)
9 (81.8)
-
2 (18.2)
6 (2.1)
3 (50.0)
3 (50.0)
-
19 (6.7)
-
12 (63.2)
7 (36.8)§
19 (6.7)
7 (36.8)
8 (42.1)
4 (21.1)
91 (32.2)
39 (42.9)
29 (31.9)
23 (25.3)
KOH†
   Positive
   Negative
69 (24.4)
59 (85.5)
10 (14.5)
86 (30.4)
80 (93.0)
6 (7.0)
28 (9.9)
28 (100.0)
-
22 (7.8)
20 (90.9)
2 (9.1)
39 (13.8)
38 (97.4)
1 (2.6)
39 (13.8)
35 (89.7)
4 (10.3)
283 (100.0)
260 (91.9)
23 (8.1)
Biopsy with D-PAS stain
   Positive (fungal hyphae or spores)
   Negative
21 (7.4)
19 (90.5)
2 (9.5)
15 (5.3)
12 (80.0)
3 (20.0)
1 (0.4)
1 (100.0)
-
3 (1.1)
2 (66.7)
1 (33.3)
1 (0.4)
1 (100.0)
-
8 (2.8)
7 (87.5)
1 (12.5)
49 (17.3)
42 (85.7)
7 (14.3)
Culture
   Trichophyton rubrum
   Trichophyton mentagrophytes
   Trichophyton tonsurans
   Trichophyton verrucosum
   Microsporum canis
   Microsporum gypseum
19 (6.7)
10 (52.6)
3 (15.8)
1 (5.3)
-
3 (15.8)
2 (10.5)
15 (5.3)
11 (73.3)
-
1 (6.7)
1 (6.7)
2 (13.3)
-
5 (1.8)
4 (80.0)
-
-
1 (20.0)
-
-
3 (1.1)
3 (100.0)
-
-
-
-
-
6 (2.1)
5 (83.3)
1 (16.7)
-
-
-
-
19 (6.7)
16 (84.2)
2 (10.5)
-
-
1 (5.3)
-
67 (23.7)
49 (73.1)
6 (9.0)
2 (3.0)
2 (3.0)
6 (9.0)
2 (3.0)
*TI involves hand and foot but confined to dorsal aspects; †KOH, potassium hydroxide examination; ‡Combined fungal disease: fungal disease which involves distant areas with 
present TI; §Tinea unguium with tinea corporis. 
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(2.5%), impetigo (1.4%), urticaria (1.2%), folliculitis (0.7%), and 
other dermatological lesions (Table 3). According to the anatom-
ical distribution, facial TI presented as eczema-like (76.8%), lu-
pus erythematosus-like (8.7%), impetigo-like (2.9%), and vitili-
go-like (2.9%) lesions. Trunk TI presented as eczema-like (79.1%) 
and psoriasis-like (10.5%) lesions, and almost all of groin, hand, 
and foot TI resembled eczema. When TI involved multiple sites, 
it appeared similar to eczema (69.2%), psoriasis (15.4%), follic-
ulitis (2.6%), and other dermatological lesions (Table 3). In chil-
dren, TI was most likely to be found in the facial area (11.6%), 
and the trunk (11.6%), and least likely to be found in the groin 
(3.6%). 
 In 91 cases (32.2%), other fungal diseases such as tinea pedis 
(42.9%), tinea unguium (31.9%), tinea pedis et unguium, or tin-
ea unguium/tinea corporis (25.3%) were diagnosed apart from 
TI sites (Table 3). According to anatomical distribution, TI of 
the trunk, groin, or hand was commonly seen with tinea pedis 
(> 50.0%), TI involving foot or multiple areas usually accompa-
nied tinea unguium, and facial TI was strongly associated with 
tinea pedis et unguium. 
Mycological data
Direct microscopic examination was performed in all cases and 
260 cases (91.9%) were positive. Of 49 biopsied specimens, 42 
(85.7%) showed fungal hyphae and/or spores by D-PAS stain. 
Sixty-seven cases (23.7%) were cultured in our study and Tricho-
phyton rubrum was the most frequently detected dermatophyte 
(49/67, 73.%), regardless of TI distribution. Trichophyton men-
tagrophytes (6/67, 9.0%) and Microsporum canis (6/67, 9.0%) 
were the second-most frequently detected causative agents, and 
T. tonsurans, T. verrucosum and M. gypseum were also isolated 
in a few cases. While only 1 or 2 species of dermatophytes were 
found in groin, hand, and foot TI, various kinds of fungi were 
identified in face or trunk TI (Table 3).
DISCUSSION
Tinea incognito had been defined as tinea modified by the im-
proper use of systemic or topical corticosteroids. However, as 
the use of topical calcineurin inhibitors has been increasing 
gradually in many dermatologic diseases such as atopic derma-
titis, seborrheic dermatitis, intertriginous psoriasis, contact der-
matitis and other dermatological lesions (12), the number of 
cases of modified tinea has also increased (7, 13, 14). Thus, we 
propose that TI be defined as certain dermatophytoses which 
have lost their usual clinical manifestation because of erroneous 
use of systemic/topical corticosteroids or topical calcineurin 
inhibitor, as in 1 recent article (2). In addition, we think that TI, 
which involves the hand or the foot, should be confined to the 
dorsal surface, because tinea pedis and tinea manus cannot be 
definitively differentiated from TI involving the palm or the sole. 
It has been suggested that the use of immunosuppressants de-
creases the fungus-induced local inflammation, and this may al-
low the fungus to grow slowly with less erythema or scaling caus-
ing a “modification” of the typical manifestation of tinea (7). 
 While TI seems to be common in dermatology practices cur-
rently, only a few numbers of large scale studies have been re-
ported (1, 2, 4). These studies were done in Italy, Spain, and Iran. 
Our study in Korea was designed to be the largest scale study 
on TI. While previous case reports of TI in Korean literature (10, 
15-21) (Table 4) showed female predominance, this study showed 
relatively equal gender distribution and relatively uniform age 
distribution (mean: 44.0 ± 22.5 yr) were found except for patients 
over 80 yr. A recent article regarding TI in Italy (1) also reported 
equal gender distribution and similar mean age (42 yr), and an-
other article in Iran (4) also revealed equal gender distribution 
with slightly younger mean age (32.6 yr). Based on these data, 
we can postulate that TI is common in middle-aged persons 
with little difference in gender. Moreover, 65 (23.0%) patients in 
our study had coexisting non-dermatologic diseases such as 
hypertension, diabetes, hepatitis, malignancy, and so on, and 
16 (5.7%) patients had coexisting dermatologic disorders requir-
ing systemic steroids or other immunosuppressants. This was 
lower than the previous Italian report in that 40% of patients 
with TI had non-dermatological pathologies which required 
treatment with systemic steroids (1). Though the percentage of 
the patients in this study who received immunosuppressive 
therapy was lower than in the Italian report, the possibility of TI 
Table 4. Previous reports of tinea incognito in Korean literatures
Case Report S/A Clinical manifestation Site Previous treatment Dermatophyte isolated
1 Yang et al. (15) F/47 Eczema-like Face, trunk, extremities Topical steroids T. mentagrophytes
2 Kang et al. (16) F/64 Eczema-like Face Topical steroids T. mentagrophytes
3 Kim et al. (17) F/70 Contact dermatitis-like Face, scalp Topical steroids T. rubrum
4 Choi et al. (10) M/8 Atopic dermatitis-like Face Topical calcineurin inhibitor T. mentagrophytes
5 Han et al. (18) M/49 Atopic dermatitis-like Face Topical and systemic steroid T. rubrum
6 Park et al. (19) F/40 Eczema-like Face Topical steroid and  
systemic antibiotics
T. mentagrophytes
7 Hwang et al. (20) F/15 Eczema-like Leg Topical steroid and  
topical calcineurin inhibitor
T. rubrum
8 Lee et al. (21) F/23 Insect bite-like Arm Topical steroids T. mentagrophytes
S/A, sex and age (years).
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should be kept in mind whenever the patient with skin lesions 
is on immunosuppressant medications. 
 There have been no published data regarding TI according 
to past treating physician’s specialty or treatment modalities, 
as yet. Based on our study, over half of the patients were either 
treated by non-dermatologists (124/283, 43.8%) or self-treated 
(44/283, 15.5%). TI was thought to be associated with easy ac-
cess to high-potency OTC topical steroids such as betametha-
sone valerate by patients and with lack of understanding of tin-
ea by non-dermatologists. Therefore, there should be swift poli-
cy changes to limit OTC access of high-potency steroids to pa-
tients in Korea. This would limit inappropriate tinea treatment 
by patients. Furthermore, to reduce the number of cases of TI 
caused by non-dermatologists, education regarding skin dis-
eases including fungal infections could be provided by Korean 
Dermatologic Associations. 
 Surprisingly, about 40% of the patients were treated by der-
matologists in this study. Even though tinea can mimic many 
other skin disorders and there could be selection bias, this ratio 
seems to be too high. This may mean a lack of mycological eval-
uation and carelessness of dermatologists when diagnosing tin-
ea infection. It is important for dermatologists to consider fun-
gal infection in the differential diagnosis of skin disorders, and 
increase the use of laboratory tests for mycological evaluation. 
In practice, the medical cost for mycological examinations is 
very low in Korea. However, the patient load is high and doctors 
are pressed for time. This could be the prime reason for misdi-
agnosis of fungal infections (22). Therefore, we think that if phy-
sicians were better paid for mycological evaluations there might 
be more active mycological examinations and fewer misdiag-
noses of fungal infections. 
 On the aspect of distribution, the trunk was the most com-
monly involved site of TI and the face was another commonly 
involved area, as reported in other original articles (1, 4) and 
previous Korean literatures. Another recent study regarding 54 
childhood TI cases also reported similar results with highest 
incidence in the trunk and face (2), and our study backed it up 
with the same results. From these findings, we can postulate 
that the most common sites of TI are trunk and face regardless 
of age. 
 The clinical features of TI were reported to be variable, and 
the most prevalent features seen are eczema-like disorders such 
as nonspecific eczema, contact dermatitis, and atopic dermati-
tis (1, 4, 7), and previous Korean reports about TI also in accor-
dance with it. Similarly, 232 TI patients in this study showed 
quite various clinical features such as eczema-like, psoriasis-
like, lupus erythematosus-like, and etc. Specifically, nearly all 
cases of hand and foot TI showed eczema-like features. There-
fore, when dealing with recalcitrant eczematous lesions on the 
hand or foot, mycological examination should always be con-
sidered. Compared to TI of groin, and hand and foot, where the 
eczema-like features were quite high, TI of the face, trunk, or 
multiple areas showed more variable features. Therefore, not 
only eczema-like lesions but also other recalcitrant skin mani-
festations resembling psoriasis, lupus erythematosus, impetigo, 
urticaria, etc., should also be carefully evaluated to rule out TI 
especially when skin diseases involve the face, the trunk, or mul-
tiple areas (Table 5). 
 Moreover, one-third of our study population (32.2%) had 
combined fungal diseases, which involved distant areas from 
present TI, and most of them had dermatophytic infection on 
their feet regardless of affected areas, including tinea pedis and 
tinea unguium. Therefore, in patients with refractory skin dis-
ease especially resembling eczema and also with concomitant 
tinea pedis or tinea unguium, TI should be ruled out because 
these coexisting fungal infections could be an autoinoculation 
source of superficial dermatophytic infection in another body 
part at any time. 
 As many previous studies confirmed (1, 23-25), Trichophyton 
rubrum (T. rubrum) was also the most frequently identified der-
matophyte. T. rubrum is one of the anthropophilic dermato-
phytes and the most common pathogen in tinea corporis, tinea 
cruris, tinea manus, tinea pedis, and tinea unguium (26). Since 
TI affecting the trunk, groin, hands, and feet accounted for al-
most 60% of T1 in our study, it would not be surprising that T. 
rubrum was the most commonly isolated dermatophyte. More-
over, the high prevalence of combined tinea pedis and tinea un-
guium might also have contributed to the high isolation rate of 
T. rubrum. Anthropophilic dermatophytes have adapted to hu-
mans and elicit a mild to non-inflammatory host response unlike 
zoophilic and geophilic infections (26). This mild inflammatory 
response might be the cause of the long duration of TI because 
topical corticosteroids or topical calcineurin inhibitor could al-
leviate the inflammation, which could be the main mechanism 
of disguising the typical manifestation of tinea. 
 In summary, our research was the largest study of TI in Korea 
to date. We investigated the characteristics of TI according to 
the primary physician’s specialty though the clinical and myco-
logical results were similar to previous studies. From this study, 
we can suggest that long-lasting erythematous scaly skin lesions 
unresponsive to steroids or calcineurin inhibitor as the most 
important risk factors of TI. Not only truncal or facial involve-
ment, but also combined tinea pedis/unguium or the history of 
immunosuppressant treatment could also be a good clue in di-
agnostic approach of TI. Moreover, we can suggest several things 
Table 5. Suggested risk factors of tinea incognito
1. Long-lasting erythematous scaly skin lesions
2. Unresponsive to steroids or calcineurin inhibitor treatment
3. Truncal or facial lesion
4. Combined tinea pedis/unguium
5. Under immunosuppressant treatment or medications
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to reduce the incidence of TI based on our results. First, reform 
of OTC sales system of high-potency topical steroids is needed 
so that they are not as easily available to the public in some coun-
tries including Korea. Second, non-dermatologists need to be 
informed and educated that superficial dermatophytic infection 
could appear in a variety of forms. Care by experienced derma-
tologists could also be needed especially when dealing with 
long-lasting erythematous scaly skin lesions, which have prov-
en to be unresponsive to steroids or calcineurin inhibitor treat-
ment. Finally, we recommend dermatologists not to neglect TI 
as a possibility in cases of recalcitrant variable skin lesions, not 
hesitating to do active mycological examinations, which would 
give them some critical clues in diagnosis of TI, and doing care-
ful clinical examinations when finding combined tinea pedis or 
tinea unguium. 
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